and grand unified theory of mental illness, 385
   			and quieting of default mode network, 313–14, 316–20
   			and spectrum of cognitive states, 313, 315, 385
   			and value of psychedelics, 313–14, 315, 385
   			environment, attitudes toward, 315–16, 359
   			environment, personal, 372–73
   			environment of psychedelic experiences
   			and bad trips, 152
   			and criticisms of psychedelic therapy, 207–8
   			Hubbard’s role in, 164, 169–70, 190
   			and Osmond and Hoffer’s research, 151, 152, 163–64
   			and “set and setting” concepts, 14, 53, 151, 190, 207–8
   			ergot, 22–23, 84
   			Esalen Institute, 47–48, 49–51
   			European Medicines Agency (EMA), 376–77
   			Evergreen State College, 101, 102
   			evolution, role of psilocybin in, 115–16
   			existential distress, 8, 78–79, 218, 223, 336–37, 353
   			expectancy effects
   			and Cohen’s ambivalence about LSD, 158
   			and expectations of therapist, 347
   			and Griffiths’s psilocybin research, 62–63, 64
   			and Huxley, 143–44, 161–62
   			and LSD therapy for alcoholism, 150
   			Exxon Valdez disaster, 88
   			Fadiman, James
   			and Alpert (later Ram Dass), 177
   			and Council on Spiritual Practices, 49
   			and creative dose of LSD, 184
   			and Hubbard, 172
   			at International Foundation for Advanced Study, 177–78, 183, 184
   			and Jesse, 43–44, 46, 49
   			as pioneer in field, 43–44
   			The Psychedelic Explorer’s Guide, 229
   			and research approval revoked by FDA, 57, 217–18
   			on Schuster, 50
   			and underground therapists, 228
   			Fahey, Todd Brendan, 165, 166, 181
   			fasting, 306
   			Federal Bureau of Investigation (FBI), 164
   			Feilding, Amanda
   			background of, 297–99
   			and Carhart-Harris, 296, 297, 299
   			cerebral circulation theory of, 298, 299, 305n
   			and research funding, 299, 300
   			Fischer, Roland, 97
   			5-HT2A receptors, 292–93, 354n
   			5-MeO-DMT (The Toad), 272–90, 291–92
   			flashbacks, 3, 209
   			Flashbacks (Leary), 139, 187, 190n
   			flight instructions
   			and cancer patient research at NYU, 338, 341
   			and Hopkins’s psilocybin research, 63, 64, 72
   			and Pollan’s psychedelic journeys, 246, 259–60
   			Fomes fomentarius, 87
   			Food of the Gods (McKenna), 115
   			forests, mycelial networks in, 91, 91n
   			Frankl, Viktor, 352n
   			Freud, Sigmund, 155, 294, 297, 307, 312, 314, 389
   			fungi
   			Claviceps purpurea, 84 (see also LSD)
   			Cordyceps, 89, 96–97
   			and forests, 91, 91n
   			Galerina autumnalis, 94
   			mycelial networks of, 84n, 90–91, 118, 122
   			and mycoremediation, 88
   			Stamets’s advocacy for, 87–90
   			See also Psilocybes
   			Fungi Perfecti operation of Stamets, 86n, 126
   			Gaia hypothesis, 359
   			Galerina autumnalis, 94
   			Gates, Bill, 175
   			Ginsberg, Allen, 193–94, 203, 205
   			Gitlin, Todd, 216
   			God experiences, 71, 343, 344, 345, 371–72
   			Goldsmith, George, 398–99, 400–401
   			Good Friday (Marsh Chapel) Experiment, 45–46, 60, 80–81, 191–92
   			Gopnik, Alison, 323–28, 329
   			Gottlieb, Sidney, 172n
   			Grant, Cary, 157
   			Graves, Robert, 107
   			Grey, Alex, 125
   			Griffiths, Roland
   			on applications for well people, 404–5
   			on authenticity questions, 76, 348–49
   			on authority of experiences, 365
   			awakening of, 33
   			background of, 31–34
   			career success of, 78
   			commitment to research, 77
   			on death, 79–80
   			and depression research, 375–76
   			and Jesse, 38, 51–52
   			on longterm changes in openness, 319–20
   			on meaning associated with psychedelic experiences, 75
   			mushroom medallions of, 82–83
   			mysteries and uncertainties embraced by, 75, 79, 80
   			on preparing volunteers for trials, 64
   			“Psilocybin Can Occasion Mystical-Type Experiences Having Substantial and Sustained Personal Meaning and Spiritual Significance,” 10–11, 29–30
   			and psilocybin trials at Hopkins, 60, 62, 65, 79, 360
   			on research at Spring Grove, 56
   			and Richards, 53
   			on Schuster, 50
   			spiritual emphasis of, 62
   			on “threats” of psychedelics, 59
   			Grinker, Roy, 208, 211
   			Grob, Charles
   			on “applied mysticism,” 207, 334
   			on first wave research, 333
   			and MDMA trials, 48
   			and shamanic paradigm, 208, 334
   			Grof, Stanislav
   			on American values, 58–59
   			on amplification effects of psychedelics, 159
   			on birth experiences, 155
   			and California Institute of Integral Studies, 232
   			at Esalen Institute, 47
   			and guides, 225, 230, 240
   			Realms of the Human Unconscious, 297
   			and Richards, 53
   			at Spring Grove, 57, 218
   			and terminal patients, 339
   			group settings, psychedelics in, 405
   			Guatemala, 114–15
   			guides
   			and bad trips, 405
   			code of ethics, 229
   			and future of psychedelics, 402–3
   			guidelines and protocols of, 226–27, 230, 230n
   			and integration of journey, 250–52, 269–71, 282, 364, 402, 405–6
   			interviews with, 231–35
   			personal experiences with psychedelics, 227
   			in Pollan’s psychedelic journeys, 237–41, 242, 254–57, 272–74
   			in psychedelic underground, 223–30
   			qualifications of, 224
   			risks assumed by, 224–25
   			role of, 215, 242, 364–65, 405–6
   			and second wave of research, 227
   			shrines or altars of, 231–32, 245–46, 254–55
   			training of, 225, 402
   			website for, 228–30
   			Guss, Jeffrey, 335, 352, 354, 369
   			habits, 360–64. See also smoking cessation
   			hacker community, 184
   			hallucinations, 310, 317
   			hallucinogens (term), 18
   			Harman, Willis
   			ambitions of, 181
   			and Hubbard, 166
   			and International Foundation for Advanced Study (IFAS), 177
   			and Jesse, 46, 49
   			and psychedelics in Silicon Valley, 176–77
   			research on creative problem solving, 179
   			and reunion of first wave figures, 219
   			at Stanford Research Institute, 180–82
   			Harvard Psilocybin Project
   			controversy surrounding, 194–97
   			criticisms of, 46, 76, 195
   			misperceptions of, 140
   			nature of experiments in, 189
   			and research of previous decade, 140, 185
   			researchers’ consumption of drugs in, 189, 195
					     					 			br />
   			and Weil, 201
   			Harvard University
   			and Concord Prison Experiment, 46, 190–91, 190n, 195
   			and Good Friday (Marsh Chapel) Experiment, 45–46, 60, 191–92
   			and James, 188, 196
   			Leary’s employment at, 140, 186–87, 201–3
   			and Leary’s psychedelic seminar, 188–89
   			and Schultes, 107
   			Hayes, John, 70, 72–73
   			Heard, Gerald, 174, 176
   			Heffter Research Institute, 48–49, 228
   			Helms, Richard, 172n
   			Hendricks, Peter, 373
   			hierarchies, psychedelics’ ability to overturn, 315
   			High Priest (Leary), 187–88
   			Hinduism, 16
   			hippies of the sixties, 203–4, 315
   			history, personal, 372–73
   			Hitchcock, Billy, 203
   			Hoffer, Abram
   			and Commission for the Study of Creative Imagination, 174
   			and Hubbard, 168, 170, 174
   			and Leary, 198
   			and LSD therapy for alcoholism, 147–52, 170
   			and psychotomimetic model, 159–60
   			and role of environment, 151
   			Hofmann, Albert
   			birthday celebration for, 21–22
   			creation of LSD-25, 1–2, 22–23
   			and Hubbard, 167
   			isolation of psilocybin and psilocin, 113
   			and mushroom conferences, 103
   			psychedelic experiences of, 23–25, 113, 142
   			on reconnection with nature, 25–26
   			and Stamets, 97, 103
   			and synthetic psilocybin, 83, 113
   			Holland, Julie, 402
   			Hollywood celebrities, 156–57, 171
   			holotropic breathwork, 242–44, 245, 245n, 306
   			honeybees and colony collapse disorder, 89, 128
   			Hoover, J. Edgar, 168
   			hospice, psychedelic, 401
   			Huautla de Jiménez in southern Mexico, 2, 108, 110, 112, 113–14
   			Hubbard, Al
   			advocacy for psychedelics, 167–68
   			ambitions of, 167–68, 173, 181, 194, 198n
   			background of, 164–67
   			and Bay Area community, 171, 175–78, 180–83
   			Captain Trips nickname, 171
   			and CIA, 166, 171–72
   			and Commission for the Study of Creative Imagination, 174–75
   			contradictions in life of, 164, 169
   			and counterculture, 181, 181n, 200
   			and environment of psychedelic experiences, 164
   			and guides, 225, 230
   			and Huxley, 172–74
   			and leading researchers, 170–71
   			and Leary, 199–200, 219, 220
   			LSD experiences of, 167
   			and mescaline, 169, 173
   			and Osmond, 168–69, 200
   			and Osmond/Hoffer’s research, 170
   			and psychedelic therapy paradigm, 160, 164, 169–70, 171, 207
   			and reunion of first wave figures, 219, 220
   			and Sandoz LSD, 167, 170
   			at Stanford Research Institute, 180–82
   			on therapeutic value of psychedelics, 169
   			and Wasson, 170
   			Human Be-In in San Francisco, 203–4
   			Humboldt, Alexander von, 126–27, 128, 134
   			Huxley, Aldous
   			ambitions of, 194, 198n
   			Brave New World, 160
   			and Commission for the Study of Creative Imagination, 174
   			death of, 338
   			The Doors of Perception, 25, 143, 160, 162, 201, 253
   			on ego, 253, 289
   			and expectancy effects, 143–44, 161–62
   			and Hubbard, 172–74
   			imprint on modern psychedelic experiences, 111, 143–44, 162
   			and Leary, 198
   			LSD experiences of, 173–74
   			mescaline experience of, 144, 151, 160–62
   			and “Mind at Large” state, 264, 315, 389
   			and Osmond, 160, 174
   			Perennial Philosophy concept of, 162, 232
   			and psychedelic therapy paradigm, 160, 207
   			and “psychedelics” term, 160, 162–63
   			“reducing valve” concept of, 161–62, 289, 307, 313, 322, 353
   			and terminal patients, 338
   			Huxley, Laura, 172
   			Hyams, Joe, 157
   			hypnagogic consciousness, 252
   			ibogaine, 369n
   			imagination, 308
   			Imperial College London’s Centre for Psychiatry, 295–96. See also Carhart-Harris, Robin
   			industrial waste, mycoremediation of, 88
   			ineffability of mystical experiences, 40, 54, 69, 251, 270, 285
   			Insel, Tom, 335, 383, 388n, 398, 401
   			interconnectedness
   			and addiction treatment, 362–63
   			Alcoholics Anonymous’s emphasis on, 370
   			and cancer patient research, 351
   			and default mode network (DMN), 305
   			and depression pilot study, 379
   			in mystical experiences, 285, 305
   			and overview effect, 359
   			and Pollan’s Psilocybes experience, 134
   			Stamets on, 125
   			International Federation for Internal Freedom (IFIF), 197, 198, 199, 203
   			International Foundation for Advanced Study (IFAS)
   			and Brand, 183
   			closure of, 180
   			Fadiman’s work at, 43–44
   			and Leary, 198
   			research approval revoked by FDA, 44, 217–18
   			research conducted at, 177–79
   			Inuit people, 13n
   			Jagger, Mick, 114
   			James, William
   			on consciousness, 16–17, 136, 137, 244, 407
   			on four hallmarks of mystical experiences, 69–72
   			on judging mystical experiences, 347
   			and mystical experience survey, 282
   			on noetic quality of mystical experiences, 41, 69–70, 275
   			and questions of veracity, 76–77
   			research at Harvard, 188, 196
   			and reunion of first wave figures, 219
   			The Varieties of Religious Experience, 69
   			Janiger, Oscar
   			and celebrities in LSD therapy, 156–57
   			and Hubbard, 171, 172
   			and LSD therapy, 156
   			and West Coast research hub, 153
   			Jesse, Bob
   			background of, 38–40, 42–43
   			behind-the-scenes work of, 37
   			and betterment of well people, 45, 51, 401–2, 404
   			cabin of, 37–38
   			and Council on Spiritual Practices, 43, 49–51, 228
   			and Doblin’s ambitions, 36
   			early psychedelic experiences of, 39–40
   			and elders of psychedelic community, 43–44
   			and Esalen Institute, 48, 49
   			and first-wave of psychedelic research, 44–45, 46–47
   			and Griffiths, 38, 51–52
   			and John Hopkins experiment, 81
   			and MDMA, 51
   			and “medicalization” concerns, 51, 400
   			and psilocybin trials at Hopkins, 10, 60
   			on “recreational use” term, 38, 400
   			and Richards, 52
   			role of, in second-wave research, 34–35
   			spiritual emphasis of, 51
   			Jobs, Steve, 175
   			Johanson, Chris-Ellyn, 50
   			John Hopkins’s psychedelic research
   			and astronaut/ground control metaphor, 65
   			with cancer patients, 8, 10–11, 332–33, 349
   			controlling for expectancy effects in, 62, 64
   			and hallmarks of mystical states, 69–72
					     					 			 />
   			landmark psilocybin paper, 10–11, 29–30
   			launch of trial, 60–61
   			preparing volunteers in, 63–65, 67
   			recruitment of volunteers for, 61
   			replication of Good Friday experiment, 192
   			and sitters, 63–64, 74
   			and Stamets, 92
   			on therapeutic applications, 78–79
   			volunteers’ accounts of, 63, 65–69, 70–71, 72–75
   			Johnson, Matthew
   			background of, 360
   			on banal insights, 364
   			and ego’s control, 388
   			and “mental reboot,” 366, 384
   			and personal history/environment, 372–73
   			on reactions to powerful experiences, 406
   			and smoking cessation study, 360, 364
   			on value of psychedelics, 366–68
   			Jung, Carl, 7, 73, 232, 389
   			Kaelen, Mendel, 384–85
   			Kaiser Hospital in Oakland, 186
   			Kalliontzi, Krystallia, 338, 340, 342
   			Katz, Sidney, 148, 154
   			Kelly, Kevin, 183
   			Kelman, Herbert, 187, 195–96
   			Keltner, Dacher, 373–74, 375
   			Kennedy, Robert F., 217
   			Kerouac, Jack, 193
   			Kesey, Ken, 102, 184, 206–7
   			Kessler, David, 383
   			Kleber, Herbert D., 29–30
   			Kleiman, Mark, 49
   			Kubrick, Stanley, 156
   			Kurland, Albert, 218
   			Laing, R. D., 223
   			League for Spiritual Discovery, 203
   			Leary, Timothy
   			arrests and sentences of, 138, 204
   			candor of, 213–14
   			and concerns of research community, 198–201
   			and Concord Prison Experiment, 46, 190–91, 190n
   			and congressional hearings, 217
   			on consciousness-expansion, 322
   			and counterculture, 203–4, 205
   			criticisms of research, 46, 191, 194–97
   			and cultural upheaval of the sixties, 205–7
   			deemed “most dangerous man in America,” 58
   			desire to effect social changes, 173, 192, 194, 198n, 199, 213
   			do-it-yourself approach of, 200, 215
   			and Eastern influences, 143–44
   			exuberance of, 187–88, 192
   			Flashbacks, 139, 187, 190n
   			and Ginsberg, 193–94, 205
   			and Good Friday (Marsh Chapel) Experiment, 191–92
   			government’s pursuit of, 204
   			and guides, 225, 230
   			at Harvard, 140, 186–87, 201–3
   			High Priest, 187–88
   			and Hubbard, 199–200, 219, 220
   			impact on psychedelic research, 9, 185–86, 190, 198–99, 212, 219–20, 403
   			and International Federation for Internal Freedom, 197, 198, 199, 203
   			and moral panic provoked by psychedelics, 185, 205
   			and Osmond, 198–99
   			post-Harvard life of, 203–6